SNY Jan 2025 42.000 call
| Previous close | 7.50 |
| Open | 7.50 |
| Bid | 5.70 |
| Ask | 6.30 |
| Strike | 42.00 |
| Expiry date | 2025-01-17 |
| Day's range | 7.50 - 12.30 |
| Contract range | N/A |
| Volume | |
| Open interest | 4 |
Insider MonkeySanofi (NASDAQ:SNY) Q1 2024 Earnings Call Transcript
Sanofi (NASDAQ:SNY) Q1 2024 Earnings Call Transcript April 25, 2024 Sanofi reports earnings inline with expectations. Reported EPS is $0.96 EPS, expectations were $0.96. Sanofi isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Paul Hudson: Welcome to the Q1 2024 conference […]
GlobeNewswirePress Release: Annual General Meeting of April 30, 2024
Annual General Meeting of April 30, 2024 Approval of the financial statements for the fiscal year 2023Distribution of a cash dividend of €3.76 per share, with payment as of May 15, 2024Board composition: renewal of two Directors and appointment of three new Independent Directors Paris, April 30, 2024. The Combined General Shareholders’ Meeting of Sanofi was held on April 30, 2024, under the chairmanship of Frédéric Oudéa. All resolutions submitted to the vote were adopted by the shareholders. Th
ZacksPharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates
Merck (MRK), Sanofi (SNY), Novartis (NVS) and AstraZeneca (AZN) announce their first-quarter results.
